Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03387098
Title QUILT-3.070: Molecularly Informed Integrated Immunotherapy Combining Innate High-affinity Natural Killer (haNK) Cell Therapy With Adenoviral and Yeast-based Vaccines to Induce T-cell Responses in Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy
Recruitment Unknown status
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors NantKwest, Inc.
Indications

pancreatic adenocarcinoma

Therapies

GI-4000

Leucovorin

Nab-paclitaxel

Bevacizumab

Avelumab

ALT-803

Fluorouracil

ETBX-011

Oxaliplatin

Aldoxorubicin

Capecitabine

Cyclophosphamide

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.